作者
Fotios Sampaziotis,Daniele Muraro,Olivia Tysoe,Stephen J. Sawiak,Timothy E. Beach,Edmund Godfrey,Sara Upponi,Teresa Brevini,Brandon T. Wesley,José Garcia‐Bernardo,Krishnaa T. Mahbubani,Giovanni Canu,Richard L. Gieseck,Natalie Lie Berntsen,Victoria Mulcahy,Keziah Crick,Corrina Fear,Sharayne Robinson,Lisa Swift,Laure Gambardella,Johannes Bargehr,Daniel Ortmann,Stephanie Brown,Anna Osnato,Michael P. Murphy,Gareth Corbett,William Gelson,George Mells,Peter Humphreys,Susan Davies,Irum Amin,Paul Gibbs,Sanjay Sinha,Sarah A. Teichmann,Andrew J. Butler,Teik Choon See,Espen Melum,Christopher J.E. Watson,Kourosh Saeb‐Parsy,Ludovic Vallier
摘要
Organoids regenerate human bile ducts Bile ducts carry bile from the liver and gall bladder to the small intestine, where it aids digestion. Cholangiocytes are epithelial cells that line bile ducts and modify bile as its transported through the biliary tree. Chronic liver diseases involving cholangiocytes account for a large fraction of liver failure and the need for liver transplantation. Because liver donors are in short supply, Sampaziotis et al. used organoid technology to develop a cell-based therapy using human tissue (see the Perspective by Kurial and Willenbring). Cholangiocyte organoids were transplanted into the intrahepatic ducts of deceased human donor livers undergoing ex vivo normothermic perfusion. The livers could be maintained for up to 100 hours, and the transplanted organoids engrafted, exhibited function, and could repair bile ducts. Science , this issue p. 839 ; see also p. 786